Literature DB >> 22030818

Effects of albumin administration in serum liver enzymes of rats in the presence of extrahepatic biliary obstruction.

Jorge Fernando Rebouças Lessa1, Leonardo Siqueira Rangel, Nilton José de Almeida Costa, Orlando Castro e Silva, Carlos Augusto Teixeira da Cruz, João Batista de Sousa.   

Abstract

PURPOSE: To study the influence of albumin on changes of liver function in the extrahepatic biliary obstruction through an experimental model in rats.
METHODS: Sixty rats were divided into four groups: Group C (Control): 6 animals. Group M (Fictitious Operation): 18 rats underwent laparotomy and handling of the bile ducts; Groups O (extrahepatic biliary obstruction) and A (Treated with 2% albumin): 18 animals in each group underwent ligation of the ductus liver; The animals in groups M, O and A were divided into three subgroups of 6 animals each to be killed in the 7, 14 and 21 days postoperative (POD). Blood was drawn for determination of total bilirubin (TB), indirect bilirubin (IB), direct bilirubin (DB), alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT).
RESULTS: On POD 7, BI levels were 4.5 mg / dl in group O and 2.1 mg / dl in group A (p = 0.025). On the 14th POD, the levels of PA were 1185.2 U / l in the group and O 458.3 U / l in group A (p = 0.004). ALT levels were 101.7 U / l in the group O and 75.7 U / l in group A (= 0.037). On POD 21, the levels of ALP were 1069.5 U / l in the group O and 468.3 U / l in group A (p = 0, 004).
CONCLUSION: The administration of albumin reduced the serum levels of bilirubin in the 7th day of supplementation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030818     DOI: 10.1590/s0102-86502011000800013

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.

Authors:  Felix Dondorf; René Fahrner; Michael Ardelt; Eleonora Patsenker; Felix Stickel; Uta Dahmen; Utz Settmacher; Falk Rauchfuß
Journal:  World J Gastroenterol       Date:  2017-06-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.